Membrane Protein Alterations Associated with Anticancer Drug Resistance in Mouse Lymphoblastic Leukemia L1210 Cells

항암제에 내성인 생쥐의 백혈병세포 L1210의 세포막 단백질의 변환

  • Kim, Seong-Yong (Department of Biochemistry College of Medicine, Yeungnam University) ;
  • Son, Sung-Kweon (Department of Biochemistry College of Medicine, Yeungnam University) ;
  • Kim, Jae-Ryong (Department of Biochemistry College of Medicine, Yeungnam University) ;
  • Kim, Jung-Hye (Department of Biochemistry College of Medicine, Yeungnam University)
  • 김성용 (영남대학교 의과대학 생화학교실) ;
  • 손성권 (영남대학교 의과대학 생화학교실) ;
  • 김재룡 (영남대학교 의과대학 생화학교실) ;
  • 김정희 (영남대학교 의과대학 생화학교실)
  • Published : 1993.12.30

Abstract

Multidrug resistance(MDR) phenotype is frequently observed in animal and human cancer cell lines selected for in vitro resistance to a single chemotherapeutic agent. It is characterized by the diminished drug accumulation and is related to the drug efflux mechanism in resistant cells. In the present study, adriamycin resistant cells(L1210-$AdR_6$ : $10^{-6}M$ adriamycin, $-AdR_5$ : $10^{-5}M$) and vincristine resistant cells (L1210-$VcR_7$ : $10^{-7}M$ vincristine, $-VcR_6$ : $10^{-6}M$) were produced from mouse lymphoblastic leukemia cell line L1210. Growth profiles of survived cells were observed for 5 days with MTT(thiazolyl blue) assay and resistance was compared with $IC_{50}$(drug concentration of 50% survival reduction in absorbance). Resistant cells proliferated more slowly than sensitive cell. Doubling times were 29.7hr in L1210, 68.7hr in L1210-$AdR_5$ and 58.2hr in $-VcR_6$. MDRs expressed as resistance factor were as follows, L1210-$AdR_5$ was 76.4 times for vincristine, L1210-$VcR_6$ was 96.4 times for adriamycin. The cell membrane proteins with three different M.W. were recognized to be related resistance, 220, 158, and 88 kd in L1210-$AdR_5$, 158, 140 and 88 kd in L1210-$VcR_6$ by SDS-PAG electrophoresis. Cell surface membrane proteins were identified by radio-iodination and autoradiogram, their molecular weights were 158, 72.8, and 42.4 Kd in L1210-$VcR_6$.

Adriamycin과 vincristine 각각에 내성인 생쥐의 림프아세포성 백혈병세포 L1210세포의 특성과 내성관계 단백질을 찾아내고 항암제의 세포내 분포를 관찰하였다. 항암제의 내성생성은 adriamycin이 $10^{-5}M$$10^{-6}M$에서 자란 세포를 L1210-$AdR_5$$-AdR_6$로 하고 vincristine은 $10^{-6}M$$10^{-7}M$에서 자란 세포를 L1210-$VcR_6$$-VcR_7$로 하였다. 감수성세포는 L1210으로 하였다. 내성세포의 성장속도는 감수성세포에 비해 느렸으며 doubling time은 L1210가 29.7시간, L1210-$AdR_5$가 68.7시간 $-VdR_6$가 58.2시간이었다. 복합내성은 내성인자로 표기되었고 L1210-$AdR_5$는 vincristine에 대해 76.4배, $-VcR_6$는 adriamycin에 대해 98.6배로 나타냈다. 감수성세포와 내성세포의 세포막 단백질을 비교한 결과 L1210-$AdR_5$에서는 220, 158, 88 Kd의 내성관계단백질이 나타났고 $-VcR_6$에서는 158, 140 및 88Kd의 내성관계단백질이 관찰되었다. 세포막 표면단백질을 $^{125}I$로 결합시켜 자가방사선상으로 분석하였다. 세포막 표면단백질에 결합되는 $^{125}I$의 정도는 L1210에 0.95% L1210-$AdR_5$에 5.4%, $-VcR_6$에 1.7%였다. 세포막표면단백질은 L1210-$AdR_5$에서는 158, 72.8 및 42.4 Kd의 단백질, $-VcR_6$에서는 300, 158, 72.8 및 42.4 Kd의 단백질이 관찰되었다.

Keywords